DAN
Dana Incorporated
DAN has the edge over TSLA overall, supported by stronger valuation and stronger modeled upside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
DAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Stable |
DAN's profitability is currently healthy, and its revenue and balance sheet are stable, but its cash flow is under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
DAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.4x | $23.26 | — |
| Cheap | 5.9x | $56.02 | +141% |
| Forward | 6.6x | $23.26 | — |
| Fair | 16x | $152 | +553% |
| Expensive | 53x | $506 | +2075% |
Historical ranges are pointers, not guarantees.
DAN has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
DAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DAN, with profitability holding steady. However, they disagree widely on these estimates.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over DAN on the outlook, with more favorable valuation expectations.
DAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | -63% |
| Q3 2026 | $9.55 | +2022% |
| Q2 2026 | $10.05 | +$10.21 |
| Q1 2026 | $10.29 | +$10.53 |
| Q4 2025 | $0.57 | +$0.96 |
| Q3 2025 | $0.45 | +$0.56 |
| Q2 2025 | -$0.16 | -$0.15 |
| Q1 2025 | -$0.24 | -367% |
| Q4 2024 | -$0.39 | -250% |
DAN has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
DAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +6.3% |
| Q2 2026 | $2B | +3.9% |
| Q1 2026 | $1.9B | -21% |
| Q4 2025 | $1.9B | -20% |
| Q3 2025 | $1.9B | -23% |
| Q2 2025 | $1.9B | -29% |
| Q1 2025 | $2.4B | -14% |
| Q4 2024 | $2.3B | -6.4% |
DAN's revenue is recovering but still below its 2023 peak: $2B last quarter, up 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +1.8 points |
| Q2 2026 | 3.8% | +2.9 points |
| Q1 2026 | 1% | -2 points |
| Q4 2025 | 3.3% | +4.9 points |
| Q3 2025 | 2.8% | -0.8 points |
| Q2 2025 | 0.8% | -3 points |
| Q1 2025 | 3.1% | +0.5 points |
| Q4 2024 | -1.5% | -2 points |
DAN has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over DAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
DAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32M | -48% |
| Q2 2026 | -$33M | -1200% |
| Q1 2026 | -$257M | -$145M |
| Q4 2025 | $345M | +132% |
| Q3 2025 | $62M | +$73M |
| Q2 2025 | $3M | -97% |
| Q1 2025 | -$112M | +$60M |
| Q4 2024 | $149M | +9.6% |
DAN has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
DAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4M shares |
| 1 year | -19% | -25.3M shares |
| 3 years | -27% | -39.2M shares |
| 5 years | -28% | -40.7M shares |
| Available history | -27% | -39.6M shares |
DAN has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200M |
| Q2 2026 | $44M |
| Q1 2026 | $125M |
| Q4 2025 | $211M |
| Q3 2025 | $182M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
DAN spent $580M buying back its own shares over the past year.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
DAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 4.9x | High |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.3x | Elevated |
DAN's net debt is about 2.1 years of its operating earnings (EBITDA), down from 5.7 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over DAN on leverage, with a lower net debt burden relative to earnings.
DAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 7.3 | Oversold |
DAN's weekly RSI is 39 (neutral) and its Stochastic is 7 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
DAN PE vs Consumer Cyclical Sector
| Metric | DAN | Sector median | Relative |
|---|---|---|---|
| PE | 2.4x | 18x | 86% below |
| PE % | 2 | 47 | 45 pts below |
DAN has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
DAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 11% below |
| 20 week MA | $27.7 | 16% below |
| 50 week MA | $29.8 | 22% below |
| 100 week MA | $23.2 | 0.4% above |
| 200 week MA | $18.3 | 27% above |
DAN has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 27% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over DAN on trend strength, trading above more of its moving averages.
DAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.6 | +6.7% |
| 2021 | $19.6 | $22.5 | +15% |
| 2022 | $22.5 | $14.9 | -34% |
| 2023 | $14.9 | $14.6 | -2.1% |
| 2024 | $14.6 | $11.7 | -20% |
| 2025 | $11.7 | $23.9 | +104% |
| 2026 YTD | $23.9 | $23.3 | -2.6% |
DAN has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.